J Korean Diabetes > Volume 16(3); 2015 > Article
The Journal of Korean Diabetes 2015;16(3):194-197.
DOI: https://doi.org/10.4093/jkd.2015.16.3.194    Published online September 30, 2015.
다낭난소증후군의 최신 치료지침
Recent Treatment Strategies for Polycystic Ovary Syndrome.
Hyejin Lee
Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea. hyejinlee@ewha.ac.kr
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-aged women. This syndrome is characterized by its heterogeneous presentation including oligoovulation, hyperandrogenism and polycystic ovary morphology. Moreover, women with PCOS exhibit metabolic dysfunction and have an increased risk of type 2 diabetes mellitus. The treatment approach is dependent on the presenting phenotype. Hormonal contraceptives are the first-line management for menstrual abnormalities and androgen excess symptoms, whereas clomiphene is the first-line therapy for infertility. Metformin is beneficial for metabolic abnormalities and menstrual irregularities.
Key Words: Androgen, Management, Polycystic ovary syndrome

Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2021 by Korean Diabetes Association. All rights reserved.

Developed in M2PI

Close layer